Ibritumomab and Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
Determining the interaction of Ibritumomab and Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab Tiuxetan
Generic Name: dasabuvir / ombitasvir / paritaprevir / ritonavir
Brand name: Viekira XR, Viekira Pak
Synonyms: Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets, and Dasabuvir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab-Omeclamox-Pak
- Ibritumomab-Omega-3 Fatty Acid Capsules
- Ibritumomab-Omega-3 Fatty Acids
- Ibritumomab-Omega-3 polyunsaturated fatty acids
- Ibritumomab-Omega-3-acid ethyl esters
- Ibritumomab-Omega-3-carboxylic acids
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Ibritumomab Intravenous
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Ibritumomab Tiuxetan
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Ibrutinib
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Ibrutinib Capsules
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Ibrutinib Tablets
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Ibu